Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
BAX · against 454 other Healthcare companies listed in US-listed
Ranked #340 of 455 · scores higher than 25% of peers
Bars: peers in each 10-point band of the growth score32 peers with a growth score of 30–39, including BAX · Click a bar to see the companies
Mainly because of its earnings per share growth, which is weaker than most Healthcare peers.
| Metric | BAX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 5.4% | 11.0% | 35% | 33% | |
| Earnings per share growthHigher is better · 171 reported | Not reported | 21.2% | — | — | 33% |
| 3-year revenue growthHigher is better · 433 reported | 4.2% | 11.0% | 31% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 337 | 2.5B USD | 34 | 32 | |
| 337 | 1.7B USD | 34 | 35 | |
| 337 | 775M USD | 34 | 31 | |
| 340 | 1.2B USD | 33 | 52 | |
| 340 | 13.2B USD | 33 | 30 | |
| 340 | 12.3B USD | 33 | 35 | |
| 343 | 838M USD | 32 | 33 | |
| 343 | 533M USD | 32 | 36 | |
| 345 | 493M USD | 31 | 38 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score